ALXO Overview
Upcoming Projects (ALXO)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ALXO)
-
Discussing the results from the Phase 2 ASPEN-06 Clinical Trial of ALX Oncology’s investigational CD47-blocking therapeutic, evorpacept, for gastric cancer
Ticker: ALXO
Executed On: Sep 11, 2024 at 05:00 PM EDT -
Discussing ALX Oncology's CD47 blocker evorpacept (ALX148) in combination with azacitidine and venetoclax in patients with AML
Ticker: ALXO
Executed On: Jan 17, 2023 at 11:00 AM EST
Expired Projects (ALXO)
-
Assessing ALX Oncology's Advancements with Evorpacept in Combatting HER2-Positive Gastric Cancer
Ticker: ALXO
Execute By: Nov 30, 2023
Upcoming & Overdue Catalysts (ALXO)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (ALXO)
